These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2174446)

  • 21. Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo.
    Suomalainen K; Sorsa T; Ingman T; Lindy O; Golub LM
    Oral Microbiol Immunol; 1992 Apr; 7(2):121-3. PubMed ID: 1326740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis.
    Asikainen S; Jousimies-Somer H; Kanervo A; Saxén L
    Arch Oral Biol; 1990; 35 Suppl():231S-234S. PubMed ID: 2088233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results.
    Walker C; Puumala S; Golub LM; Stoner JA; Reinhardt RA; Lee HM; Payne JB
    J Periodontol; 2007 Aug; 78(8):1590-601. PubMed ID: 17668979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility.
    Thomas J; Walker C; Bradshaw M
    J Periodontol; 2000 Sep; 71(9):1472-83. PubMed ID: 11022778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular source and tetracycline-inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus.
    Sorsa T; Ingman T; Suomalainen K; Halinen S; Saari H; Konttinen YT; Uitto VJ; Golub LM
    J Clin Periodontol; 1992 Feb; 19(2):146-9. PubMed ID: 1318330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical use of tetracyclines in the treatment of periodontal diseases].
    Bokor-Bratić M; Brkanić T
    Med Pregl; 2000; 53(5-6):266-71. PubMed ID: 11089368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems.
    Golub LM; Goodson JM; Lee HM; Vidal AM; McNamara TF; Ramamurthy NS
    J Periodontol; 1985 Nov; 56(11 Suppl):93-7. PubMed ID: 3001266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized-controlled trial of low-dose doxycycline for periodontitis in smokers.
    Needleman I; Suvan J; Gilthorpe MS; Tucker R; St George G; Giannobile W; Tonetti M; Jarvis M
    J Clin Periodontol; 2007 Apr; 34(4):325-33. PubMed ID: 17324155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term sub-antimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: effects on subgingival bacterial population dynamics.
    Thomas JG; Metheny RJ; Karakiozis JM; Wetzel JM; Crout RJ
    Adv Dent Res; 1998 Nov; 12(2):32-9. PubMed ID: 9972119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Subgingival Doxycycline Placement on Clinical and Microbiological Parameters in Inflammatory Periodontal Disease: Both in Vivo and in Vitro Studies.
    Mahajania M; Laddha R; Shelke A; Gadhiya N; Narkhede S; Shetty GP
    J Contemp Dent Pract; 2018 Oct; 19(10):1228-1234. PubMed ID: 30498178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis.
    Takafuji ET; Kirkpatrick JW; Miller RN; Karwacki JJ; Kelley PW; Gray MR; McNeill KM; Timboe HL; Kane RE; Sanchez JL
    N Engl J Med; 1984 Feb; 310(8):497-500. PubMed ID: 6363930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between gingival fluid measurements and macroscopic and microscopic characteristics of gingival tissue.
    Daneshmand H; Wade AB
    J Periodontal Res; 1976 Feb; 11(1):35-46. PubMed ID: 130478
    [No Abstract]   [Full Text] [Related]  

  • 33. Bioenergetics in clinical medicine. VI. adjunctive treatment of periodontal disease with coenzyme Q10.
    Wilkinson EG; Arnold RM; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):715-9. PubMed ID: 785563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tetracycline resistance in oral microorganisms in patients with periodontal disease].
    Olsvik B
    Nor Tannlaegeforen Tid; 1991 Jan; 101(2):50-2. PubMed ID: 1861963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources.
    Golub LM; Wolff M; Lee HM; McNamara TF; Ramamurthy NS; Zambon J; Ciancio S
    J Periodontal Res; 1985 Jan; 20(1):12-23. PubMed ID: 2983061
    [No Abstract]   [Full Text] [Related]  

  • 36. Tetracycline: levels of achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part II. Susceptibilities of periodontal bacteria.
    Walker CB; Gordon JM; McQuilkin SJ; Niebloom TA; Socransky SS
    J Periodontol; 1981 Oct; 52(10):613-6. PubMed ID: 7028940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospects for improving the prevention of inflammatory periodontal disease.
    Alfano MC
    J Prev Dent; 1978; 5(1):26-8. PubMed ID: 376827
    [No Abstract]   [Full Text] [Related]  

  • 38. Concentration of doxycycline in human gingival fluid.
    Pascale D; Gordon J; Lamster I; Mann P; Seiger M; Arndt W
    J Clin Periodontol; 1986 Oct; 13(9):841-4. PubMed ID: 3537018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rationale for the management of periodontal diseases: effects of tetracycline on subgingival bacteria.
    Rams TE; Keyes PH
    J Am Dent Assoc; 1983 Jul; 107(1):37-41. PubMed ID: 6348123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The evaluation of the efficacy of antibiotic therapy in human periodontal disease].
    Cigana F; Doumenjou F
    Bull Group Int Rech Sci Stomatol Odontol; 1989 Dec; 32(4):227-37. PubMed ID: 2636550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.